| Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart G Torre-Amione, S Kapadia, J Lee, JB Durand, RD Bies, JB Young, ... Circulation 93 (4), 704-711, 1996 | 1417 | 1996 |
| Cardiotoxicity of the cancer therapeutic agent imatinib mesylate R Kerkelä, L Grazette, R Yacobi, C Iliescu, R Patten, C Beahm, B Walters, ... Nature medicine 12 (8), 908-916, 2006 | 1406 | 2006 |
| Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline SH Armenian, C Lacchetti, A Barac, J Carver, LS Constine, N Denduluri, ... Journal of Clinical Oncology 35 (8), 893-911, 2017 | 1267 | 2017 |
| Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management ETH Yeh, AT Tong, DJ Lenihan, SW Yusuf, J Swafford, C Champion, ... Circulation 109 (25), 3122-3131, 2004 | 1060 | 2004 |
| Reversibility of trastuzumab-related cardiotoxicity: new insights based on clinical course and response to medical treatment MS Ewer, MT Vooletich, JB Durand, ML Woods, JR Davis, V Valero, ... Journal of Clinical Oncology 23 (31), 7820-7826, 2005 | 866 | 2005 |
| Modifiable risk factors and major cardiac events among adult survivors of childhood cancer GT Armstrong, KC Oeffinger, Y Chen, T Kawashima, Y Yasui, ... Journal of clinical oncology 31 (29), 3673-3680, 2013 | 720 | 2013 |
| Long-term cardiac tolerability of trastuzumab in metastatic breast cancer: the MD Anderson Cancer Center experience V Guarneri, DJ Lenihan, V Valero, JB Durand, K Broglio, KR Hess, ... Journal of Clinical Oncology 24 (25), 4107-4115, 2006 | 463 | 2006 |
| Initial assessment, surveillance, and management of blood pressure in patients receiving vascular endothelial growth factor signaling pathway inhibitors ML Maitland, GL Bakris, HR Black, HX Chen, JB Durand, WJ Elliott, SP Ivy, ... Journal of the National Cancer Institute 102 (9), 596-604, 2010 | 455 | 2010 |
| Immune checkpoint inhibitor myocarditis: pathophysiological characteristics, diagnosis, and treatment N Palaskas, J Lopez‐Mattei, JB Durand, C Iliescu, A Deswal Journal of the American Heart Association 9 (2), e013757, 2020 | 353 | 2020 |
| Screening adult survivors of childhood cancer for cardiomyopathy: comparison of echocardiography and cardiac magnetic resonance imaging GT Armstrong, JC Plana, N Zhang, D Srivastava, DM Green, KK Ness, ... Journal of clinical oncology 30 (23), 2876-2884, 2012 | 346 | 2012 |
| Heart failure associated with sunitinib malate: a multitargeted receptor tyrosine kinase inhibitor AY Khakoo, CM Kassiotis, N Tannir, JC Plana, M Halushka, C Bickford, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2008 | 316 | 2008 |
| Decreased expression of tumor necrosis factor-α in failing human myocardium after mechanical circulatory support: a potential mechanism for cardiac recovery G Torre-Amione, SJ Stetson, KA Youker, JB Durand, B Radovancevic, ... Circulation 100 (11), 1189-1193, 1999 | 298 | 1999 |
| Congestive heart failure is a rare event in patients receiving imatinib therapy E Atallah, JB Durand, H Kantarjian, J Cortes Blood, The Journal of the American Society of Hematology 110 (4), 1233-1237, 2007 | 294 | 2007 |
| Sunitinib‐induced cardiotoxicity is mediated by off‐target inhibition of AMP‐activated protein kinase R Kerkela, KC Woulfe, JB Durand, R Vagnozzi, D Kramer, TF Chu, ... Clinical and translational science 2 (1), 15-25, 2009 | 261 | 2009 |
| Differential expression of heat shock proteins in normal and failing human hearts AA Knowlton, S Kapadia, G Torre-Amione, JB Durand, R Bies, J Young, ... Journal of molecular and cellular cardiology 30 (4), 811-818, 1998 | 207 | 1998 |
| Localization of a gene responsible for familial dilated cardiomyopathy to chromosome 1q32 JB Durand, LL Bachinski, LC Bieling, GZ Czernuszewicz, AB Abchee, ... Circulation 92 (12), 3387-3389, 1995 | 185 | 1995 |
| Novel cardiac troponin T mutation as a cause of familial dilated cardiomyopathy D Li, GZ Czernuszewicz, O Gonzalez, T Tapscott, A Karibe, JB Durand, ... Circulation 104 (18), 2188-2193, 2001 | 179 | 2001 |
| Hemodynamic effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients with class III to IV congestive heart failure G Torre-Amione, JB Young, JB Durand, B Bozkurt, DL Mann, I Kobrin, ... Circulation 103 (7), 973-980, 2001 | 173 | 2001 |
| Treatment and outcomes of acute coronary syndrome in the cancer population SW Yusuf, N Daraban, N Abbasi, X Lei, JB Durand, IN Daher Clinical cardiology 35 (7), 443-450, 2012 | 141 | 2012 |
| Impact of aspirin therapy in cancer patients with thrombocytopenia and acute coronary syndromes MG Sarkiss, SW Yusuf, CL Warneke, G Botz, N Lakkis, C Hirch‐Ginsburg, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2007 | 139 | 2007 |
Syed Wamique YusufUniversity of Texas MD Anderson Cancer Center在 mdanderson.org 的电子邮件经过验证
